Clinical applications of MS-based protein quantification

Mass spectrometry-based assays are increasingly important in clinical laboratory medicine and nowadays are already commonly used in several areas of routine diagnostics. These include therapeutic drug monitoring, toxicology, endocrinology, pediatrics, and microbiology. Accordingly, some of the most...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sabbagh, Bassel (VerfasserIn) , Mindt, Sonani (VerfasserIn) , Neumaier, Michael (VerfasserIn) , Findeisen, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 06 January 2016
In: Proteomics. Clinical applications
Year: 2016, Jahrgang: 10, Heft: 4, Pages: 323-345
ISSN:1862-8354
DOI:10.1002/prca.201500116
Online-Zugang:Verlag, Volltext: https://doi.org/10.1002/prca.201500116
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201500116
Volltext
Verfasserangaben:Bassel Sabbagh, Sonani Mindt, Michael Neumaier, Peter Findeisen
Beschreibung
Zusammenfassung:Mass spectrometry-based assays are increasingly important in clinical laboratory medicine and nowadays are already commonly used in several areas of routine diagnostics. These include therapeutic drug monitoring, toxicology, endocrinology, pediatrics, and microbiology. Accordingly, some of the most common analyses are therapeutic drug monitoring of immunosuppressants, vitamin D, steroids, newborn screening, and bacterial identification. However, MS-based quantification of peptides and proteins for routine diagnostic use is rather rare up to now despite excellent analytical specificity and good sensitivity. Here, we want to give an overview over current fit-for-purpose assays for MS-based protein quantification. Advantages as well as challenges of this approach will be discussed with focus on feasibility for routine diagnostic use.
Beschreibung:Gesehen am 23.04.2019
Beschreibung:Online Resource
ISSN:1862-8354
DOI:10.1002/prca.201500116